Rimidi Diabetes Financing
Rimidi Diabetes, Inc., Corporation just filed form D for $1.20 million debt financing. The date of first sale was 2015-12-18. Rimidi Diabetes was able to finance itself with $700,000 so far. That is 58.33% of the round of financing. The total private offering amount was $1.20 million. The fundraising form was filed on 2016-11-03. The reason for the financing was: unspecified. The fundraising still has about $500,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Rimidi Diabetes is based in Georgia. The filler’s business is Other Health Care. The form was submitted by Lucienne Ide President. The company was incorporated in 2012. The filler’s address is: 400 Trabert Avenue, #8, Atlanta, Ga, Georgia, 30309. Lucienne Marie Ide is the related person in the form and it has address: 400 Trabert Avenue, #8, Atlanta, Ga, Georgia, 30309. Link to Rimidi Diabetes Filing: 000155627216000003.
Analysis of Rimidi Diabetes Offering
On average, firms in the Other Health Care sector, sell 68.60% of the total offering amount. Rimidi Diabetes sold 58.33% of the offering. The financing is still open. The average investment offering size for companies in the Other Health Care industry is $1.16 million. The offering was 39.66% smaller than the average of $1.16 million. Of course this should not be interpreted as negative. Startups raise funds for a variety of needs and reasons. The minimum investment for this financing is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Rimidi Diabetes Also
The Form D signed by Lucienne Ide might help Rimidi Diabetes, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.